Navari is a Swedish startup founded in 2021, with a mission to advance minimally invasive soft tissue cancer surgery through augmented reality. The company's slogan "Revolutionizing minimally invasive soft tissue cancer surgery with AR" encapsulates its core objective. Navari's innovative software tool utilizes AR to enhance the precision of tumor removal, thereby facilitating safer and quicker surgeries. By providing surgeons with intuitive navigation capabilities, Navari ensures optimal tumor localization and removal.
Navari's recent milestone includes securing a kr5.30M Seed Round investment on 09 August 2022, with Chalmers Ventures as the lead investor. This backing underlines confidence in Navari's potential to transform cancer surgery. Operating in the manufacturing industry, Navari's disruptive approach holds promise for improving medical outcomes and shaping the future of surgical interventions.